Rocket Pharmaceuticals Warrant
RCKTW
10 hedge funds and large institutions have $164K invested in Rocket Pharmaceuticals Warrant in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
1% less capital invested
Capital invested by funds: $165K → $164K (-$1.25K)
17% less funds holding
Funds holding: 12 → 10 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$80 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$401 |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$30 |
| 3 |
CS
Clear Street
New York
|
-$2 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $132K | – | – | – |
|
|
RI
2
RTW Investments
New York
| $7.21K | – | – | – |
|
|
SCM
3
Sio Capital Management
New York
| $7.02K | – | – | – |
|
|
4
Citadel Advisors
Miami,
Florida
| $6.51K | -$30 | -1,492 | -0.5% |
|
5
Walleye Capital
New York
| $5.86K | – | – | – |
|
|
SCM
6
Silverarc Capital Management
Boston,
Massachusetts
| $2.16K | – | – | – |
|
|
LP
7
LMR Partners
London,
United Kingdom
| $1.56K | – | – | – |
|
|
AAA
8
Affinity Asset Advisors
New York
| $1.18K | – | – | – |
|
|
AA
9
Ancora Advisors
Cleveland,
Ohio
| $124 | – | – | – |
|
|
10
UBS Group
Zurich,
Switzerland
| $84 | +$80 | +3,981 | New |
|
|
TSS
11
Two Sigma Securities
New York
| – | -$401 | -16,500 | Closed |
|
|
CS
12
Clear Street
New York
| – | -$2 | -100 | Closed |
|
RCKTW Hedge Fund Activity: Q1 2026 in Review
10 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals Warrant (RCKTW) for Q1 2026, worth a combined $164K — down 0.76% from $165K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of RCKTW and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $80. The largest seller was Two Sigma Securities, exiting entirely with an estimated $401 sold.
- 10 institutional investors held Rocket Pharmaceuticals Warrant (RCKTW) as of Q1 2026, down from 12 in Q4 2025.
- Funds reported $164K of Rocket Pharmaceuticals Warrant stock for Q1 2026, down 0.76% quarter-over-quarter.
- 1 fund opened new Rocket Pharmaceuticals Warrant positions in Q1 2026 and 3 closed out, a net change of -2 holders.
- The largest Rocket Pharmaceuticals Warrant buyer in Q1 2026 was UBS Group, an estimated $80 added.
- The largest Rocket Pharmaceuticals Warrant seller in Q1 2026 was Two Sigma Securities, an estimated $401 sold.
Based on aggregated 13F filings for Q1 2026.